HeartBeat.bio
Wien, Austria
HeartBeat.bio is a VC funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies. Our core technology is based on the world-wide first, self-organizing cardiac organoids (Cardioids) which resemble the human physiology of a human heart chamber in a way that allows for the cost-efficient and large scale in-vitro analysis of crucial clinical parameters associated with various cardiac diseases. The Cardioid-based screening platform has the potential to radically change the current cardiovascular drug discovery paradigm.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2021
- Website
- www.heartbeat.bio/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of HeartBeat.bio?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now